MRK: Sac-TMT Gets FDA Breakthrough Therapy Designation For EGFR-mutated Advanced Or Metastatic NSCLC
Merck & Co., Inc. (MRK) announced Tuesday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...
I’m a doctor — female nonsmokers get lung cancer more than men, look out for these troubling signs
"The odds of beating lung cancer are increasingly good as time goes on," said Dr. Daniel Sterman, the division director for ...
Cure Today19h
Tiragolumab Plus Tecentriq Misses Survival Endpoint for Lung Cancer Subset
The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some ...
Community Impact Newspaper6h
2 UT Health SA scientists awarded grants for innovative cancer research
In recognition of their innovative cancer research, two scientists at the University of Texas Health Science Center at San ...
BioPharma Dive7d
Roche’s TIGIT-targeting drug for cancer fails its biggest test
Long-awaited results released Tuesday showed adding tiragolumab to Roche's immunotherapy Tecentriq did not extend survival in ...